Skip to content

Acupressure therapy in premenstrual syndrome

Compare the effect of acupressure therapy and Fluoxetine on the symptoms of premenstrual syndrome: A randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190430043433N1
Enrollment
90
Registered
2019-05-11
Start date
2019-05-22
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstural syndrome. Premenstrual tension syndrome

Interventions

Intervention 1: IThe first intervention group: received acupressure completely free of charge for 15 minutes in the second half of the menstrual cycle for 12 days in a one day interval, namely 6 sessi

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: The desire to participate in the study Regular menstruation from 24 to 35 days The normalization of the length and volume of menstrual bleeding is 3-10 days Age range 18 to 35 years Having a Body Mass (25 -5/18) . Having symptoms of premenstrual syndrome in two cycles before starting the intervention Non-Depression Based on the Beck Questionnaire Having a phone number to follow

Exclusion criteria

Exclusion criteria: Having known psychological illnesses (according to the person) Use of any drug for the treatment of premenstrual syndrome Tobacco use, narcotics and psychotropic drugs (according to the person) Having regular exercise Use of antidepressants, sedation and hormones and vitamin supplements There are skin lesions in acupressure points A stressful incident in the past six months, such as: separation of parents, death of first-degree family members, and .... Use of any drug that has fluoxetine interactions

Design outcomes

Primary

MeasureTime frame
Physical symptoms of premenstrual syndrome. Timepoint: Two months before the intervention, during the intervention, three months after the end of the intervention. Method of measurement: Daily Record of Severity of Problems chart.;Psychosomatic symptoms of premenstrual syndrome. Timepoint: Two months before the intervention, during the intervention, three months after the end of the intervention. Method of measurement: Daily Record of Severity of Problems chart.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Zarabadipour

Qazvin University of Medical Sciences

z.zarabadipour@qums.ac.ir+98 28 3333 8034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026